| Positive Rankings |
Oversold Stochastics
Syndax Pharmaceuticals rank is 149 |
Low vPut/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.15 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 324. |
Low Put/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.12 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 361. |
90 Day Gain
Syndax Pharmaceuticals rank is 430 |
Debt-to-Equity
Syndax Pharmaceuticals rank is 652 |
Up EPS Surprise
Syndax Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings. |
| Negative Rankings |
Negative Net Margin
Syndax Pharmaceuticals rank is 85 |
Price-to-Sales
Syndax Pharmaceuticals rank is 92 |
10 Day Loss
Syndax Pharmaceuticals rank is 153 |
Negative ROE
Syndax Pharmaceuticals rank is 471 |
Negative ROA
Syndax Pharmaceuticals rank is 487 |
Price-to-Book
Syndax Pharmaceuticals rank is 1914 |
